Skip to content

The role of PVAT in vascular ageing in chronic kidney disease and type 2 diabetes.

The role of PVAT in vascular ageing in chronic kidney disease and type 2 diabetes.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23667
Enrollment
Unknown
Registered
2018-10-01
Start date
2018-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accelerated vascular ageing Chronic kidney disease Type 2 diabetes

Interventions

Not applicable.

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Kidney donors: - Men and women - Age above 17 years Kidney recipients: - Men and women - Age above 17 years - Kidney failure leading to transplantation

Exclusion criteria

Exclusion criteria: - Inadequate spreaking of Dutch language - Age below 18 years - Incompetent

Design outcomes

Primary

MeasureTime frame
•Characterization of the pro-inflammatory and pro-calcifying environment of PVAT as compared to subcutaneous fat (SAT) •Identification of potential differences in inflammatory profile between PVAT obtained from ‘healthy’ and calcified arterial wall •Assessment of the effects on SMC calcification, dedifferentiation and contractile function in vitro of PVAT (compared to SAT)

Secondary

MeasureTime frame
- Role of type 2 diabetes mellitus in PVAT dysfunction - Differences between end-stage renal disease and pre-emptive renal transplant recipients in its role of PVAT dysfunction

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)